Iran, Islamic Republic of vs Sudan: Average cost of multi drug-resistant tuberculosis treatment
Iran, Islamic Republic of
28,730 constant 2022 US$
in 2022
Sudan
51,726 constant 2022 US$
in 2023
Iran, Islamic Republic of rank
3rd
Sudan rank
1st
Average cost of multi drug-resistant tuberculosis treatment over time
- Iran, Islamic Republic of
- Sudan
How they compare
Sudan currently reports 51,726 constant 2022 US$ against 28,730 constant 2022 US$ in Iran, Islamic Republic of, a difference of 22,996 constant 2022 US$.
That makes Sudan's figure about 1.8 times Iran, Islamic Republic of's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Sudan ahead.
Iran, Islamic Republic of ranks 3rd and Sudan ranks 1st of 92 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8,842 constant 2022 US$ | 2,275 constant 2022 US$ | 6,567 constant 2022 US$ | Iran, Islamic Republic of |
| 2020s | 20,687 constant 2022 US$ | 1,153 constant 2022 US$ | 19,534 constant 2022 US$ | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Iran, Islamic Republic of or Sudan?
- Sudan, at 51,726 constant 2022 US$ against 28,730 constant 2022 US$ in Iran, Islamic Republic of as of 2023.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Iran, Islamic Republic of and Sudan?
- 22,996 constant 2022 US$, with Sudan ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Sudan?
- 6 years are reported by both, from 2017 to 2022.
- How do Iran, Islamic Republic of and Sudan rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Iran, Islamic Republic of ranks 3rd and Sudan ranks 1st of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.